Observational studyClinical drug investigation2021

Long-Term Effectiveness of Natalizumab in Patients with Relapsing-Remitting Multiple Sclerosis Treated in the Routine Care in Greece: Results from the Multicenter, Observational 5-Year Prospective Study 'TOPICS Greece'.

Dardiotis Efthimios et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.